Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0239946 (
liver fibrosis
)
8,268
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Upon gene inactivation in animal models, the zebrafish (
Danio rerio
) has become a useful model organism for many reasons, including the fact that it is amenable to various forms of genetic manipulation. Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified, or replaced in the genome of a living organism. Mainly, CRISPR (clustered regularly interspaced short palindromic repeats) Cas9 (CRISPR-associated protein 9) is a technology that enables geneticists to edit parts of the genome. In this study, we utilized this technology to generate an
mmp15b
mutant by using zebrafish as an animal model.
MMP15
is the membrane-type MMP (MT-MMP) which is a recently identified matrix metalloproteinase (MMP) capable of degrading all kinds of extracellular matrix proteins as well as numerous bioactive molecules. Although the newly-established
mmp15b
zebrafish mutant didn't exhibit morphological phenotypes in the developing embryos, it might be further utilized to understand the role of
MMP15
in liver-related diseases, such as
liver fibrosis
, and associated pathogeneses in humans.
...
PMID:Generation of
mmp15b
Zebrafish Mutant to Investigate Liver Diseases. 3199 44